Abstracts Archive - Page 341 of 1683 - ATC Abstracts

2020 American Transplant Congress
A Data-Driven Approach to Defining the Volume-Outcome Relationship in Renal Transplantation
E. L. Godfrey¹, M. D. Bailey¹, W. C. Frankel¹, A. Rana²
¹Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: Advances in immunosuppression and management continually improve short- and long-term outcomes of renal transplantation. However, center volume and expertise, while commonly believed to affect…
2020 American Transplant Congress
The Importance of Annual Medicare Part D Plan Evaluation in Heart Transplantation
L. M. Lourenco
Pharmacy Services, University of Chicago Medicine, Chicago, IL
*Purpose: The Medicare open enrollment period is from Oct 15 to Dec 7, annually. The purpose of this project was to objectively measure the benefit…
2020 American Transplant Congress
Assessment of HEALTh LIteracy on MEdication ADheREnce and Graft Outcomes in KIdney Transplant Recipients (Hallmark)
M. Leung¹, A. Dhanda², S. Kwan³, A. Zienkiewicz³, E. Waters³, N. Wood³, L. Young³, C. Bannon³
¹Pharmacy, St. Paul's Hospital, Vancouver, BC, Canada, ²Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ³Nephrology, St. Paul's Hospital, Vancouver, BC, Canada
*Purpose: Upon successful kidney transplantation, many patients have difficulty adhering to their new immunosuppression medication regimens. Previous studies have established low health literacy to be…
2020 American Transplant Congress
The Effect of Donor Transaminase Levels on Graft Survival Following Liver Transplantation: An OPTN Database Analysis
I. A. Ziogas¹, P. N. Martins², S. P. Alexopoulos¹, L. K. Matsuoka¹, S. K. Geevarghese¹, L. D. Gorden¹, S. J. Karp¹, J. D. Perkins³, M. I. Montenovo¹
¹Vanderbilt University Medical Center, Nashville, TN, ²UMass Memorial Medical Center, Worcester, MA, ³University of Washington, Seattle, WA
*Purpose: The scarcity of organs for liver transplantation (LT) does not meet the increased demand for donor grafts. Although the outcomes of LT utilizing grafts…
2020 American Transplant Congress
Clinical Features and Transplant Outcomes in Kidney Transplant Recipients with Renal Cell Carcinoma
C. Baek, H. Kim, S. Park
Asan Medical Center, Seoul, Korea, Republic of
*Purpose: Previous studies have recommended a 2-5-year waiting time prior to kidney transplantation (KT) in patients with end-stage renal disease (ESRD) and symptomatic renal cell…
2020 American Transplant Congress
A Comprehensive Evaluation of Risk Factors for Pneumocystis Jiroveci Pneumonia in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
N. Permpalung¹, V. Kittipibul², P. Mekraksakit³, P. Rattanawong⁴, S. Nematollahi¹, S. Mehta-Steinke¹
¹Johns Hopkins University School of Medicine, Baltimore, MD, ²University of Miami/Jackson Memorial Hospital, Miami, FL, ³Texas Tech University Health Sciences, Lubbock, TX, ⁴Mayo Clinic, Phoenix, AZ
*Purpose: Pneumocytis jiroveci pneumonia (PJP) is an important opportunistic fungal infection in solid organ transplant (SOT) recipients that carries a significant morbidity and mortality. Several…
2020 American Transplant Congress
Supporting “The Decision Project:” Understanding Perceptions of Organ, Eye, and Tissue Donation among Baltimore City Community Members
M. Johnson¹, A. Saha¹, M. Waldram¹, I. Johnson², L. Price², A. Coleman², C. Alexander², D. Segev¹, M. Henderson¹
¹Johns Hopkins, Baltimore, MD, ²The Living Legacy Foundation of Maryland, Halethorpe, MD
*Purpose: Using information provided by the Maryland Motor Vehicle Administration (MVA), it was found that the zip code 21205 in Baltimore City had one of…
2020 American Transplant Congress
Implementation of a Pharmacist in an Adult Transplant Outpatient Clinic (Kidney, Liver, Pancreas): A Pilot Study – Implant
P. Leveille-Dugas¹, C. Bernard¹, L. Loiselle¹, Y. Zhang¹, C. Coursol¹, K. Mousseau¹, N. Sheehan¹, M. Cantarovich²
¹Pharmacy, McGill University Health Centre, Montréal, QC, Canada, ²Division of Nephrology, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada
*Purpose: Solid organ transplant (SOT) patients require a complex medication regimen which increases the risk of many drug-related problems. The purpose of this study was…
2020 American Transplant Congress
The Level of Plasm Donor-Derived Cell-Free DNA in Kidney Transplant Patients with Severe Pneumonia
L. Liu¹, H. Liu², F. Liu², L. Shu², L. Peng¹
¹Xiangyang Hospital No. 2 of Central South University, Changsha, China, ²AlloDx, Shanghai; Suzhou, China
*Purpose: Pulmonary infection is one of the common complications after kidney transplantation. Donor-derived cell-free DNA (ddcfDNA) is a new biomarker to diagnose allograft injury. Currently,…
2020 American Transplant Congress
Use of Cell Saver Leads to Lower Consumption of Blood Products During Liver Transplantation
R. Danc
Anesthesiology, Ikem, Prague, Czech Republic
*Purpose: Liver transplantation is often accompanied by significant blood loss and consequently a large consumption of blood products. In recent years, there has been a…